Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies
Authors:
Open Access
- 17 February 2016
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 9 (6) , 1584-1595
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Towards an HIV cure: a global scientific strategyNature Reviews Immunology, 2012
- A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in MacaquesJournal of Virology, 2012
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleenNature Immunology, 2011
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectantProceedings of the National Academy of Sciences, 2011
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV InfectionCell Host & Microbe, 2010
- Neutrophil kinetics in health and diseaseTrends in Immunology, 2010
- Relative Transmissibility of an R5 Clade C Simian‐Human Immunodeficiency Virus Across Different Mucosae in Macaques Parallels the Relative Risks of Sexual HIV‐1 Transmission in Humans via Different RoutesThe Journal of Infectious Diseases, 2010
- Glycerol monolaurate prevents mucosal SIV transmissionNature, 2009